Skip to content

Turbo II

by Kinetic Concepts, Inc.

510(k) K933402

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK933402 Date15 Mar 1994ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FNM
Device Class
Class II
Regulation
21 CFR Part 880.5550
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Turbo II is an Air Flotation, Alternating Pressure Mattress, designed to provide pressure redistribution and support for patients at risk of pressure ulcers or requiring off-loading therapy. It uses alternating air cells to cycle pressure, reducing sustained pressure points and promoting circulation in immobilized or bedridden individuals.

This device is intended for use in general hospital settings and is supplied as a reusable, non-sterile mattress. It is classified as a Class II device under FDA regulation 880.5550 and was cleared via a Traditional 510(k) pathway (K933402). The Turbo II operates without MRI compatibility restrictions and is available in standard sizes as referenced in the regulatory filings. Storage and maintenance instructions are detailed in the manufacturer’s documentation.

Other devices from Kinetic Concepts, Inc.

  • Cowboy II

    Class II
  • Kinair, Low Air Loss Bed

    Class II
  • Vacplus

    Class II
  • Modified Pedikair

    Class II
  • Glenn Bed

    Class II
  • Premium

    Class II

See all devices from Kinetic Concepts, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Turbo II Air Flotation Mattress designed for?

    The Turbo II is specifically designed to provide pressure redistribution and support for patients at risk of developing pressure ulcers or requiring off-loading therapy. It uses alternating air cells to cycle pressure, reducing sustained pressure points and promoting circulation in immobilized or bedridden individuals, particularly in general hospital settings.

  • How is the Turbo II supplied and what are its sterility and reuse characteristics?

    The Turbo II is supplied as a reusable mattress and is non-sterile. This means it is intended for repeated use in clinical environments after proper cleaning and maintenance, as outlined in the manufacturer’s documentation, rather than being single-use or sterile.

  • What sizes are available for the Turbo II?

    The Turbo II is available in standard sizes, though the exact dimensions are not specified in the provided data. The regulatory filings reference multiple FEI numbers, indicating various models or configurations may exist, but specific measurements would require consulting the manufacturer’s documentation or product catalog.

  • Can the Turbo II be used with MRI equipment?

    No, the Turbo II is not MRI-compatible. This means it should not be used in MRI environments, as the alternating air cells could interfere with MRI imaging or pose safety risks during the procedure.

  • What regulatory pathway was followed for the Turbo II’s clearance?

    The Turbo II was cleared through the FDA’s Traditional 510(k) pathway, specifically under the classification of a Class II device (FDA regulation 880.5550). This pathway demonstrates that the device was determined to be substantially equivalent to a legally marketed predicate device, ensuring its safety and effectiveness for its intended use.